Cobalis Corp. (CLSC.PK) Partners with BESPHarma, LLC to Launch Physician Office Distribution for PreHistin(R)
8/6/2010 8:31:42 AM
IRVINE, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Cobalis Corp. (Pink Sheets: CLSC) announced today that it has entered into a 5-year distribution partnership agreement with Florida-based BESPHarma, LLC to launch a national distribution program wherein physicians and healthcare providers can offer their patients PreHistin® Allergy Defense Formula directly in their offices. BESPHarma, a specialty healthcare product distribution and marketing company, has a well-developed network of approximately 20,000 physician's offices across the U.S. that have created in-office dispensaries for various medications, providing patients with the convenience of immediate access to their prescription drugs. PreHistin® represents the first non-prescription supplement to be added into the physicians' office dispensary program.
This marks one of the most significant milestones for Cobalis building a fully-integrated marketing and sales program for PreHistin®, by adding the physician, a patient's most trusted health advisor, as an advocate and direct source of PreHistin® for their patients who suffer from seasonal (outdoor) and year-round (indoor) allergies.
BESPHarma Managing Partner Pamela Willis said: "With 1 out of every 5 Americans suffering from allergies, and over 17 million outpatient doctor visits annually to treat allergy symptoms, we see a perfect fit to make PreHistin® immediately available to consumers at the most effective moment in their healthcare: right at the doctor's office. We believe physicians will, in large numbers, quickly adopt providing their allergy patients with a safe, non-drowsy alternative to after-the-symptom antihistamines to help them restore a normal response to allergens. We are excited to partner with Cobalis and represent this unique new approach to allergy care to doctors across the U.S. We are now preparing to introduce PreHistin® to our core network of physicians immediately."
Marty Marion, Cobalis CEO said: "To a consumer suffering from allergies, there is no more important or trusted factor than the advice of their doctor. Making PreHistin® available right at their physician's office is important on several levels. First, it is an opportunity to introduce and build the PreHistin® brand and its benefits to nearly 20,000 physician's offices and their patients. Further, as BESPHarma accelerates placement of PreHistin® throughout their network of physicians' offices, we will see substantial sales of PreHistin® in the very near term. We are very pleased to announce this partnership with BESPHarma and prepare to launch this major sales program immediately."
ABOUT BESPHarma LLC
BESPHarma, LLC is an industry leader in the marketing and distribution of specialty healthcare products to physicians, retailer and other specialty chains. At BESPHarma, LLC we are committed to the needs of our clients and to providing a one-stop shop for bringing new products to the marketplace.
ABOUT COBALIS CORPPREHISTIN®
Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, The World's FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.
For PreHistin® product information and ordering please visit at www.PreHistin.com or call toll free 1-877-4POLLEN. For additional company information please visit the corporate website at www.Cobalis.com.
16795 Von Karman, Suite 200
Irvine, CA 92606
Chas Radovich, President
Martin Marion, CEO
SOURCE Cobalis Corp.